Wire Stories

Category Added in a WPeMatico Campaign

GENEXINE_CI

Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of...

logo-90

World Community and Individual Services Market Opportunity and Strategy Report 2022 with Focus on World Food Program, UNICEF, Sanctuary Housing, Food For Poor, & The Bill & Melinda Gates Foundation – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Community And Individual Services Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering....